VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
21 hedge funds and large institutions have $973K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 0 closing their positions.
Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
4
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BAM
1
Belpointe Asset Management
Reno,
Nevada
|
$11.9K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$9.09K |
| 3 |
E
3
Ergoteles
New York
|
$7.9K |
| 4 |
SG
4
StoneX Group
New York
|
$7.22K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$7.35K |
